Drug therapies for chronic conditions and risk of Alzheimer's disease and related dementias: A scoping review-Reference-Cited by-同舟云学术

Drug therapies for chronic conditions and risk of Alzheimer's disease and related dementias: A scoping review

Published:2020-10-08 Issue:1 Volume:17 Page:41-48
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Thunell Johanna¹,Chen Yi²,Joyce Geoffrey³,Barthold Douglas⁴,Shekelle Paul G.⁵,Brinton Roberta Diaz⁶,Zissimopoulos Julie⁷

Affiliation:

1. Schaeffer Center for Health Policy and Economics University of Southern California Los Angeles California USA

2. Price School of Public Policy University of Southern California Los Angeles California USA

3. School of Pharmacy Schaeffer Center for Health Policy and Economics University of Southern California Los Angeles California USA

4. The Comparative Health Outcomes Policy, and Economics (CHOICE) Institute, School of Pharmacy University of Washington Seattle Washington USA

5. UCLA School of Medicine, VA Medical Center RAND Corporation Los Angeles California USA

6. Department of Pharmacology and Neurology, Center for Innovation in Brain Science University of Arizona Tucson Arizona USA

7. Price School of Public Policy, Schaeffer Center for Health Policy and Economics University of Southern California Los Angeles California USA

Funder

National Science Foundation

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12175

Reference54 articles.

1. The five‐five, ten‐ten plan for Alzheimer's disease;Khachaturian Z;Neurobiol Aging,1992

2. The Value of Delaying Alzheimer’s Disease Onset

3. The impact of changes in population health and mortality on future prevalence of Alzheimer's disease and other dementias in the United States;Zissimopoulos JM;J Gerontol B Psychol Sci Soc Sci,2018

4. 2019 Alzheimer's disease facts and figures

5. The worldwide societal costs of dementia: Estimates for 2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CLADSI: Deep Continual Learning for Alzheimer's Disease Stage Identification Using Accelerometer Data;IEEE Journal of Biomedical and Health Informatics;2024-06

2. Association between colchicine use and the risk of dementia among patients with gout: A nationwide retrospective cohort study;International Journal of Rheumatic Diseases;2024-05

3. An assessment of the mediating role of hypertension in the effect of long-term air pollution exposure on dementia;Environmental Epidemiology;2024-04-12

4. Re‐remembering the influence of randomized β‐carotene on cognitive decline;Alzheimer's & Dementia;2023-03-20

5. Regular proton pump inhibitor use and incident dementia: population-based cohort study;BMC Medicine;2022-09-01